| Planned Parenthood Mar Monte, Inc | |
|
6095 N 1st St Fresno CA 93710-5444 | |
| (559) 446-1515 | |
| (559) 446-1273 |
| Full Name | Planned Parenthood Mar Monte, Inc |
|---|---|
| Speciality | Clinic/Center |
| Location | 6095 N 1st St, Fresno, California |
| Authorized Official Name and Position | Tom Motsiff (CFO) |
| Authorized Official Contact | 4087953707 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Planned Parenthood Mar Monte, Inc 1691 The Alameda San Jose CA 95126-2203 Ph: (408) 795-3600 | Planned Parenthood Mar Monte, Inc 6095 N 1st St Fresno CA 93710-5444 Ph: (559) 446-1515 |
| NPI Number | 1023062593 |
|---|---|
| Provider Enumeration Date | 05/20/2006 |
| Last Update Date | 07/25/2019 |
| Medicare PECOS PAC ID | 1456248954 |
|---|---|
| Medicare Enrollment ID | O20041029000856 |
News Archive
Over the past twenty years, the use of nanoparticles in medicine has steadily increased. However, their safety and effect on the human immune system remains an important concern.
GenVec, Inc. today announced that it has signed a research collaboration agreement with the Laboratory of Malaria Immunology and Vaccinology of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.
A small survey of U.S. obstetrics and gynecology residents finds that fewer than one in five receives formal training in menopause medicine, and that seven in 10 would like to receive it.
The first two research projects supported by the Pfizer-FRSQ Innovation Fund will investigate differences in the genetic code for inflammatory bowel disease and metastatic colorectal cancer. This research could lead to improved diagnosis and the development of individualized treatments for these diseases. These innovative projects are marshalling multidisciplinary teams of seasoned researchers from major Quebec research institutions.
Bangkok Hospital Group is working with IBM (NYSE: IBM) to enhance its patient care services to provide smarter healthcare in Thailand. Delivering on its commitment to provide the highest quality, internationally-accepted standards of medical services, Bangkok Hospital Group continues to invest in best-in-class information technology.
› Verified 2 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023062593 | NPI | - | NPPES |
| CMM70669G | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QC1500X | Clinic/center - Community Health | 040000294 (California) | Primary |
| Provider Name | Kathleen Ann Kimball |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1801907100 PECOS PAC ID: 9335180371 Enrollment ID: I20050519000497 |
News Archive
Over the past twenty years, the use of nanoparticles in medicine has steadily increased. However, their safety and effect on the human immune system remains an important concern.
GenVec, Inc. today announced that it has signed a research collaboration agreement with the Laboratory of Malaria Immunology and Vaccinology of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.
A small survey of U.S. obstetrics and gynecology residents finds that fewer than one in five receives formal training in menopause medicine, and that seven in 10 would like to receive it.
The first two research projects supported by the Pfizer-FRSQ Innovation Fund will investigate differences in the genetic code for inflammatory bowel disease and metastatic colorectal cancer. This research could lead to improved diagnosis and the development of individualized treatments for these diseases. These innovative projects are marshalling multidisciplinary teams of seasoned researchers from major Quebec research institutions.
Bangkok Hospital Group is working with IBM (NYSE: IBM) to enhance its patient care services to provide smarter healthcare in Thailand. Delivering on its commitment to provide the highest quality, internationally-accepted standards of medical services, Bangkok Hospital Group continues to invest in best-in-class information technology.
› Verified 2 days ago
| Provider Name | Christine M Grisbach Smith |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1316058662 PECOS PAC ID: 1153353248 Enrollment ID: I20050909000413 |
News Archive
Over the past twenty years, the use of nanoparticles in medicine has steadily increased. However, their safety and effect on the human immune system remains an important concern.
GenVec, Inc. today announced that it has signed a research collaboration agreement with the Laboratory of Malaria Immunology and Vaccinology of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.
A small survey of U.S. obstetrics and gynecology residents finds that fewer than one in five receives formal training in menopause medicine, and that seven in 10 would like to receive it.
The first two research projects supported by the Pfizer-FRSQ Innovation Fund will investigate differences in the genetic code for inflammatory bowel disease and metastatic colorectal cancer. This research could lead to improved diagnosis and the development of individualized treatments for these diseases. These innovative projects are marshalling multidisciplinary teams of seasoned researchers from major Quebec research institutions.
Bangkok Hospital Group is working with IBM (NYSE: IBM) to enhance its patient care services to provide smarter healthcare in Thailand. Delivering on its commitment to provide the highest quality, internationally-accepted standards of medical services, Bangkok Hospital Group continues to invest in best-in-class information technology.
› Verified 2 days ago
| Provider Name | Cheryl Anne Balaoing |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1932336377 PECOS PAC ID: 1254478241 Enrollment ID: I20091023000306 |
News Archive
Over the past twenty years, the use of nanoparticles in medicine has steadily increased. However, their safety and effect on the human immune system remains an important concern.
GenVec, Inc. today announced that it has signed a research collaboration agreement with the Laboratory of Malaria Immunology and Vaccinology of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.
A small survey of U.S. obstetrics and gynecology residents finds that fewer than one in five receives formal training in menopause medicine, and that seven in 10 would like to receive it.
The first two research projects supported by the Pfizer-FRSQ Innovation Fund will investigate differences in the genetic code for inflammatory bowel disease and metastatic colorectal cancer. This research could lead to improved diagnosis and the development of individualized treatments for these diseases. These innovative projects are marshalling multidisciplinary teams of seasoned researchers from major Quebec research institutions.
Bangkok Hospital Group is working with IBM (NYSE: IBM) to enhance its patient care services to provide smarter healthcare in Thailand. Delivering on its commitment to provide the highest quality, internationally-accepted standards of medical services, Bangkok Hospital Group continues to invest in best-in-class information technology.
› Verified 2 days ago
| Provider Name | Amanda Villani |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1386028363 PECOS PAC ID: 9436468485 Enrollment ID: I20151028001940 |
News Archive
Over the past twenty years, the use of nanoparticles in medicine has steadily increased. However, their safety and effect on the human immune system remains an important concern.
GenVec, Inc. today announced that it has signed a research collaboration agreement with the Laboratory of Malaria Immunology and Vaccinology of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.
A small survey of U.S. obstetrics and gynecology residents finds that fewer than one in five receives formal training in menopause medicine, and that seven in 10 would like to receive it.
The first two research projects supported by the Pfizer-FRSQ Innovation Fund will investigate differences in the genetic code for inflammatory bowel disease and metastatic colorectal cancer. This research could lead to improved diagnosis and the development of individualized treatments for these diseases. These innovative projects are marshalling multidisciplinary teams of seasoned researchers from major Quebec research institutions.
Bangkok Hospital Group is working with IBM (NYSE: IBM) to enhance its patient care services to provide smarter healthcare in Thailand. Delivering on its commitment to provide the highest quality, internationally-accepted standards of medical services, Bangkok Hospital Group continues to invest in best-in-class information technology.
› Verified 2 days ago
| Provider Name | Margaux Helene Lazarin |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1952628422 PECOS PAC ID: 5799912937 Enrollment ID: I20160707001740 |
News Archive
Over the past twenty years, the use of nanoparticles in medicine has steadily increased. However, their safety and effect on the human immune system remains an important concern.
GenVec, Inc. today announced that it has signed a research collaboration agreement with the Laboratory of Malaria Immunology and Vaccinology of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.
A small survey of U.S. obstetrics and gynecology residents finds that fewer than one in five receives formal training in menopause medicine, and that seven in 10 would like to receive it.
The first two research projects supported by the Pfizer-FRSQ Innovation Fund will investigate differences in the genetic code for inflammatory bowel disease and metastatic colorectal cancer. This research could lead to improved diagnosis and the development of individualized treatments for these diseases. These innovative projects are marshalling multidisciplinary teams of seasoned researchers from major Quebec research institutions.
Bangkok Hospital Group is working with IBM (NYSE: IBM) to enhance its patient care services to provide smarter healthcare in Thailand. Delivering on its commitment to provide the highest quality, internationally-accepted standards of medical services, Bangkok Hospital Group continues to invest in best-in-class information technology.
› Verified 2 days ago
| Provider Name | Monalisa Ann Lafountain-rivera |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1215164645 PECOS PAC ID: 9133404411 Enrollment ID: I20170329000735 |
News Archive
Over the past twenty years, the use of nanoparticles in medicine has steadily increased. However, their safety and effect on the human immune system remains an important concern.
GenVec, Inc. today announced that it has signed a research collaboration agreement with the Laboratory of Malaria Immunology and Vaccinology of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.
A small survey of U.S. obstetrics and gynecology residents finds that fewer than one in five receives formal training in menopause medicine, and that seven in 10 would like to receive it.
The first two research projects supported by the Pfizer-FRSQ Innovation Fund will investigate differences in the genetic code for inflammatory bowel disease and metastatic colorectal cancer. This research could lead to improved diagnosis and the development of individualized treatments for these diseases. These innovative projects are marshalling multidisciplinary teams of seasoned researchers from major Quebec research institutions.
Bangkok Hospital Group is working with IBM (NYSE: IBM) to enhance its patient care services to provide smarter healthcare in Thailand. Delivering on its commitment to provide the highest quality, internationally-accepted standards of medical services, Bangkok Hospital Group continues to invest in best-in-class information technology.
› Verified 2 days ago
| Provider Name | Madison Jay Beal |
|---|---|
| Provider Type | Practitioner - Certified Nurse Midwife (cnm) |
| Provider Identifiers | NPI Number: 1821506866 PECOS PAC ID: 9830450782 Enrollment ID: I20180309001778 |
News Archive
Over the past twenty years, the use of nanoparticles in medicine has steadily increased. However, their safety and effect on the human immune system remains an important concern.
GenVec, Inc. today announced that it has signed a research collaboration agreement with the Laboratory of Malaria Immunology and Vaccinology of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.
A small survey of U.S. obstetrics and gynecology residents finds that fewer than one in five receives formal training in menopause medicine, and that seven in 10 would like to receive it.
The first two research projects supported by the Pfizer-FRSQ Innovation Fund will investigate differences in the genetic code for inflammatory bowel disease and metastatic colorectal cancer. This research could lead to improved diagnosis and the development of individualized treatments for these diseases. These innovative projects are marshalling multidisciplinary teams of seasoned researchers from major Quebec research institutions.
Bangkok Hospital Group is working with IBM (NYSE: IBM) to enhance its patient care services to provide smarter healthcare in Thailand. Delivering on its commitment to provide the highest quality, internationally-accepted standards of medical services, Bangkok Hospital Group continues to invest in best-in-class information technology.
› Verified 2 days ago
| Provider Name | Prabhjot Dhadda |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1376046300 PECOS PAC ID: 3375805575 Enrollment ID: I20180328002297 |
News Archive
Over the past twenty years, the use of nanoparticles in medicine has steadily increased. However, their safety and effect on the human immune system remains an important concern.
GenVec, Inc. today announced that it has signed a research collaboration agreement with the Laboratory of Malaria Immunology and Vaccinology of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.
A small survey of U.S. obstetrics and gynecology residents finds that fewer than one in five receives formal training in menopause medicine, and that seven in 10 would like to receive it.
The first two research projects supported by the Pfizer-FRSQ Innovation Fund will investigate differences in the genetic code for inflammatory bowel disease and metastatic colorectal cancer. This research could lead to improved diagnosis and the development of individualized treatments for these diseases. These innovative projects are marshalling multidisciplinary teams of seasoned researchers from major Quebec research institutions.
Bangkok Hospital Group is working with IBM (NYSE: IBM) to enhance its patient care services to provide smarter healthcare in Thailand. Delivering on its commitment to provide the highest quality, internationally-accepted standards of medical services, Bangkok Hospital Group continues to invest in best-in-class information technology.
› Verified 2 days ago
| Provider Name | Sara T Terashima |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1649768086 PECOS PAC ID: 3577818046 Enrollment ID: I20181115001618 |
News Archive
Over the past twenty years, the use of nanoparticles in medicine has steadily increased. However, their safety and effect on the human immune system remains an important concern.
GenVec, Inc. today announced that it has signed a research collaboration agreement with the Laboratory of Malaria Immunology and Vaccinology of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.
A small survey of U.S. obstetrics and gynecology residents finds that fewer than one in five receives formal training in menopause medicine, and that seven in 10 would like to receive it.
The first two research projects supported by the Pfizer-FRSQ Innovation Fund will investigate differences in the genetic code for inflammatory bowel disease and metastatic colorectal cancer. This research could lead to improved diagnosis and the development of individualized treatments for these diseases. These innovative projects are marshalling multidisciplinary teams of seasoned researchers from major Quebec research institutions.
Bangkok Hospital Group is working with IBM (NYSE: IBM) to enhance its patient care services to provide smarter healthcare in Thailand. Delivering on its commitment to provide the highest quality, internationally-accepted standards of medical services, Bangkok Hospital Group continues to invest in best-in-class information technology.
› Verified 2 days ago
| Provider Name | Lillian Froughieh Hartman |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1407347271 PECOS PAC ID: 8921345612 Enrollment ID: I20190204002603 |
News Archive
Over the past twenty years, the use of nanoparticles in medicine has steadily increased. However, their safety and effect on the human immune system remains an important concern.
GenVec, Inc. today announced that it has signed a research collaboration agreement with the Laboratory of Malaria Immunology and Vaccinology of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.
A small survey of U.S. obstetrics and gynecology residents finds that fewer than one in five receives formal training in menopause medicine, and that seven in 10 would like to receive it.
The first two research projects supported by the Pfizer-FRSQ Innovation Fund will investigate differences in the genetic code for inflammatory bowel disease and metastatic colorectal cancer. This research could lead to improved diagnosis and the development of individualized treatments for these diseases. These innovative projects are marshalling multidisciplinary teams of seasoned researchers from major Quebec research institutions.
Bangkok Hospital Group is working with IBM (NYSE: IBM) to enhance its patient care services to provide smarter healthcare in Thailand. Delivering on its commitment to provide the highest quality, internationally-accepted standards of medical services, Bangkok Hospital Group continues to invest in best-in-class information technology.
› Verified 2 days ago
| Provider Name | Sarah Elizabeth Gold |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1821651175 PECOS PAC ID: 9234465865 Enrollment ID: I20190719001481 |
News Archive
Over the past twenty years, the use of nanoparticles in medicine has steadily increased. However, their safety and effect on the human immune system remains an important concern.
GenVec, Inc. today announced that it has signed a research collaboration agreement with the Laboratory of Malaria Immunology and Vaccinology of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.
A small survey of U.S. obstetrics and gynecology residents finds that fewer than one in five receives formal training in menopause medicine, and that seven in 10 would like to receive it.
The first two research projects supported by the Pfizer-FRSQ Innovation Fund will investigate differences in the genetic code for inflammatory bowel disease and metastatic colorectal cancer. This research could lead to improved diagnosis and the development of individualized treatments for these diseases. These innovative projects are marshalling multidisciplinary teams of seasoned researchers from major Quebec research institutions.
Bangkok Hospital Group is working with IBM (NYSE: IBM) to enhance its patient care services to provide smarter healthcare in Thailand. Delivering on its commitment to provide the highest quality, internationally-accepted standards of medical services, Bangkok Hospital Group continues to invest in best-in-class information technology.
› Verified 2 days ago
| Provider Name | Namrata Mastey |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1720475411 PECOS PAC ID: 1850621822 Enrollment ID: I20190918002047 |
News Archive
Over the past twenty years, the use of nanoparticles in medicine has steadily increased. However, their safety and effect on the human immune system remains an important concern.
GenVec, Inc. today announced that it has signed a research collaboration agreement with the Laboratory of Malaria Immunology and Vaccinology of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.
A small survey of U.S. obstetrics and gynecology residents finds that fewer than one in five receives formal training in menopause medicine, and that seven in 10 would like to receive it.
The first two research projects supported by the Pfizer-FRSQ Innovation Fund will investigate differences in the genetic code for inflammatory bowel disease and metastatic colorectal cancer. This research could lead to improved diagnosis and the development of individualized treatments for these diseases. These innovative projects are marshalling multidisciplinary teams of seasoned researchers from major Quebec research institutions.
Bangkok Hospital Group is working with IBM (NYSE: IBM) to enhance its patient care services to provide smarter healthcare in Thailand. Delivering on its commitment to provide the highest quality, internationally-accepted standards of medical services, Bangkok Hospital Group continues to invest in best-in-class information technology.
› Verified 2 days ago
| Provider Name | Cassy Friedrich |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1427469782 PECOS PAC ID: 3971834169 Enrollment ID: I20191021000969 |
News Archive
Over the past twenty years, the use of nanoparticles in medicine has steadily increased. However, their safety and effect on the human immune system remains an important concern.
GenVec, Inc. today announced that it has signed a research collaboration agreement with the Laboratory of Malaria Immunology and Vaccinology of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.
A small survey of U.S. obstetrics and gynecology residents finds that fewer than one in five receives formal training in menopause medicine, and that seven in 10 would like to receive it.
The first two research projects supported by the Pfizer-FRSQ Innovation Fund will investigate differences in the genetic code for inflammatory bowel disease and metastatic colorectal cancer. This research could lead to improved diagnosis and the development of individualized treatments for these diseases. These innovative projects are marshalling multidisciplinary teams of seasoned researchers from major Quebec research institutions.
Bangkok Hospital Group is working with IBM (NYSE: IBM) to enhance its patient care services to provide smarter healthcare in Thailand. Delivering on its commitment to provide the highest quality, internationally-accepted standards of medical services, Bangkok Hospital Group continues to invest in best-in-class information technology.
› Verified 2 days ago
| Provider Name | Courtney M Wilmot |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1093338873 PECOS PAC ID: 8022435239 Enrollment ID: I20200902003094 |
News Archive
Over the past twenty years, the use of nanoparticles in medicine has steadily increased. However, their safety and effect on the human immune system remains an important concern.
GenVec, Inc. today announced that it has signed a research collaboration agreement with the Laboratory of Malaria Immunology and Vaccinology of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.
A small survey of U.S. obstetrics and gynecology residents finds that fewer than one in five receives formal training in menopause medicine, and that seven in 10 would like to receive it.
The first two research projects supported by the Pfizer-FRSQ Innovation Fund will investigate differences in the genetic code for inflammatory bowel disease and metastatic colorectal cancer. This research could lead to improved diagnosis and the development of individualized treatments for these diseases. These innovative projects are marshalling multidisciplinary teams of seasoned researchers from major Quebec research institutions.
Bangkok Hospital Group is working with IBM (NYSE: IBM) to enhance its patient care services to provide smarter healthcare in Thailand. Delivering on its commitment to provide the highest quality, internationally-accepted standards of medical services, Bangkok Hospital Group continues to invest in best-in-class information technology.
› Verified 2 days ago
| Provider Name | Lauren N Salmo |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1952914095 PECOS PAC ID: 4486073269 Enrollment ID: I20200928002575 |
News Archive
Over the past twenty years, the use of nanoparticles in medicine has steadily increased. However, their safety and effect on the human immune system remains an important concern.
GenVec, Inc. today announced that it has signed a research collaboration agreement with the Laboratory of Malaria Immunology and Vaccinology of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.
A small survey of U.S. obstetrics and gynecology residents finds that fewer than one in five receives formal training in menopause medicine, and that seven in 10 would like to receive it.
The first two research projects supported by the Pfizer-FRSQ Innovation Fund will investigate differences in the genetic code for inflammatory bowel disease and metastatic colorectal cancer. This research could lead to improved diagnosis and the development of individualized treatments for these diseases. These innovative projects are marshalling multidisciplinary teams of seasoned researchers from major Quebec research institutions.
Bangkok Hospital Group is working with IBM (NYSE: IBM) to enhance its patient care services to provide smarter healthcare in Thailand. Delivering on its commitment to provide the highest quality, internationally-accepted standards of medical services, Bangkok Hospital Group continues to invest in best-in-class information technology.
› Verified 2 days ago
| Provider Name | Charlotte Scott |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1548799059 PECOS PAC ID: 3375871676 Enrollment ID: I20210208001457 |
News Archive
Over the past twenty years, the use of nanoparticles in medicine has steadily increased. However, their safety and effect on the human immune system remains an important concern.
GenVec, Inc. today announced that it has signed a research collaboration agreement with the Laboratory of Malaria Immunology and Vaccinology of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.
A small survey of U.S. obstetrics and gynecology residents finds that fewer than one in five receives formal training in menopause medicine, and that seven in 10 would like to receive it.
The first two research projects supported by the Pfizer-FRSQ Innovation Fund will investigate differences in the genetic code for inflammatory bowel disease and metastatic colorectal cancer. This research could lead to improved diagnosis and the development of individualized treatments for these diseases. These innovative projects are marshalling multidisciplinary teams of seasoned researchers from major Quebec research institutions.
Bangkok Hospital Group is working with IBM (NYSE: IBM) to enhance its patient care services to provide smarter healthcare in Thailand. Delivering on its commitment to provide the highest quality, internationally-accepted standards of medical services, Bangkok Hospital Group continues to invest in best-in-class information technology.
› Verified 2 days ago
| Provider Name | Rachel Thornton |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1033703038 PECOS PAC ID: 6305241563 Enrollment ID: I20210826000239 |
News Archive
Over the past twenty years, the use of nanoparticles in medicine has steadily increased. However, their safety and effect on the human immune system remains an important concern.
GenVec, Inc. today announced that it has signed a research collaboration agreement with the Laboratory of Malaria Immunology and Vaccinology of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.
A small survey of U.S. obstetrics and gynecology residents finds that fewer than one in five receives formal training in menopause medicine, and that seven in 10 would like to receive it.
The first two research projects supported by the Pfizer-FRSQ Innovation Fund will investigate differences in the genetic code for inflammatory bowel disease and metastatic colorectal cancer. This research could lead to improved diagnosis and the development of individualized treatments for these diseases. These innovative projects are marshalling multidisciplinary teams of seasoned researchers from major Quebec research institutions.
Bangkok Hospital Group is working with IBM (NYSE: IBM) to enhance its patient care services to provide smarter healthcare in Thailand. Delivering on its commitment to provide the highest quality, internationally-accepted standards of medical services, Bangkok Hospital Group continues to invest in best-in-class information technology.
› Verified 2 days ago
| Provider Name | Maria Tuite |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1093481350 PECOS PAC ID: 4587061221 Enrollment ID: I20210923001456 |
News Archive
Over the past twenty years, the use of nanoparticles in medicine has steadily increased. However, their safety and effect on the human immune system remains an important concern.
GenVec, Inc. today announced that it has signed a research collaboration agreement with the Laboratory of Malaria Immunology and Vaccinology of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.
A small survey of U.S. obstetrics and gynecology residents finds that fewer than one in five receives formal training in menopause medicine, and that seven in 10 would like to receive it.
The first two research projects supported by the Pfizer-FRSQ Innovation Fund will investigate differences in the genetic code for inflammatory bowel disease and metastatic colorectal cancer. This research could lead to improved diagnosis and the development of individualized treatments for these diseases. These innovative projects are marshalling multidisciplinary teams of seasoned researchers from major Quebec research institutions.
Bangkok Hospital Group is working with IBM (NYSE: IBM) to enhance its patient care services to provide smarter healthcare in Thailand. Delivering on its commitment to provide the highest quality, internationally-accepted standards of medical services, Bangkok Hospital Group continues to invest in best-in-class information technology.
› Verified 2 days ago
| Provider Name | Hannah Brown |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1265104293 PECOS PAC ID: 2466840707 Enrollment ID: I20211019002502 |
News Archive
Over the past twenty years, the use of nanoparticles in medicine has steadily increased. However, their safety and effect on the human immune system remains an important concern.
GenVec, Inc. today announced that it has signed a research collaboration agreement with the Laboratory of Malaria Immunology and Vaccinology of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.
A small survey of U.S. obstetrics and gynecology residents finds that fewer than one in five receives formal training in menopause medicine, and that seven in 10 would like to receive it.
The first two research projects supported by the Pfizer-FRSQ Innovation Fund will investigate differences in the genetic code for inflammatory bowel disease and metastatic colorectal cancer. This research could lead to improved diagnosis and the development of individualized treatments for these diseases. These innovative projects are marshalling multidisciplinary teams of seasoned researchers from major Quebec research institutions.
Bangkok Hospital Group is working with IBM (NYSE: IBM) to enhance its patient care services to provide smarter healthcare in Thailand. Delivering on its commitment to provide the highest quality, internationally-accepted standards of medical services, Bangkok Hospital Group continues to invest in best-in-class information technology.
› Verified 2 days ago
| Provider Name | Trang Thu Tran |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1285184135 PECOS PAC ID: 9537553763 Enrollment ID: I20220303001089 |
News Archive
Over the past twenty years, the use of nanoparticles in medicine has steadily increased. However, their safety and effect on the human immune system remains an important concern.
GenVec, Inc. today announced that it has signed a research collaboration agreement with the Laboratory of Malaria Immunology and Vaccinology of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.
A small survey of U.S. obstetrics and gynecology residents finds that fewer than one in five receives formal training in menopause medicine, and that seven in 10 would like to receive it.
The first two research projects supported by the Pfizer-FRSQ Innovation Fund will investigate differences in the genetic code for inflammatory bowel disease and metastatic colorectal cancer. This research could lead to improved diagnosis and the development of individualized treatments for these diseases. These innovative projects are marshalling multidisciplinary teams of seasoned researchers from major Quebec research institutions.
Bangkok Hospital Group is working with IBM (NYSE: IBM) to enhance its patient care services to provide smarter healthcare in Thailand. Delivering on its commitment to provide the highest quality, internationally-accepted standards of medical services, Bangkok Hospital Group continues to invest in best-in-class information technology.
› Verified 2 days ago
| Provider Name | Clarissa Mae Domingo-javier |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1811696883 PECOS PAC ID: 6204296551 Enrollment ID: I20230718002144 |
News Archive
Over the past twenty years, the use of nanoparticles in medicine has steadily increased. However, their safety and effect on the human immune system remains an important concern.
GenVec, Inc. today announced that it has signed a research collaboration agreement with the Laboratory of Malaria Immunology and Vaccinology of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.
A small survey of U.S. obstetrics and gynecology residents finds that fewer than one in five receives formal training in menopause medicine, and that seven in 10 would like to receive it.
The first two research projects supported by the Pfizer-FRSQ Innovation Fund will investigate differences in the genetic code for inflammatory bowel disease and metastatic colorectal cancer. This research could lead to improved diagnosis and the development of individualized treatments for these diseases. These innovative projects are marshalling multidisciplinary teams of seasoned researchers from major Quebec research institutions.
Bangkok Hospital Group is working with IBM (NYSE: IBM) to enhance its patient care services to provide smarter healthcare in Thailand. Delivering on its commitment to provide the highest quality, internationally-accepted standards of medical services, Bangkok Hospital Group continues to invest in best-in-class information technology.
› Verified 2 days ago
| Provider Name | Stephanie Anne Ng |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1558131235 PECOS PAC ID: 5890148985 Enrollment ID: I20240124004468 |
News Archive
Over the past twenty years, the use of nanoparticles in medicine has steadily increased. However, their safety and effect on the human immune system remains an important concern.
GenVec, Inc. today announced that it has signed a research collaboration agreement with the Laboratory of Malaria Immunology and Vaccinology of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.
A small survey of U.S. obstetrics and gynecology residents finds that fewer than one in five receives formal training in menopause medicine, and that seven in 10 would like to receive it.
The first two research projects supported by the Pfizer-FRSQ Innovation Fund will investigate differences in the genetic code for inflammatory bowel disease and metastatic colorectal cancer. This research could lead to improved diagnosis and the development of individualized treatments for these diseases. These innovative projects are marshalling multidisciplinary teams of seasoned researchers from major Quebec research institutions.
Bangkok Hospital Group is working with IBM (NYSE: IBM) to enhance its patient care services to provide smarter healthcare in Thailand. Delivering on its commitment to provide the highest quality, internationally-accepted standards of medical services, Bangkok Hospital Group continues to invest in best-in-class information technology.
› Verified 2 days ago
| Provider Name | Kelly Jean Garrison Garmur |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1700195260 PECOS PAC ID: 1456794817 Enrollment ID: I20240213002333 |
News Archive
Over the past twenty years, the use of nanoparticles in medicine has steadily increased. However, their safety and effect on the human immune system remains an important concern.
GenVec, Inc. today announced that it has signed a research collaboration agreement with the Laboratory of Malaria Immunology and Vaccinology of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.
A small survey of U.S. obstetrics and gynecology residents finds that fewer than one in five receives formal training in menopause medicine, and that seven in 10 would like to receive it.
The first two research projects supported by the Pfizer-FRSQ Innovation Fund will investigate differences in the genetic code for inflammatory bowel disease and metastatic colorectal cancer. This research could lead to improved diagnosis and the development of individualized treatments for these diseases. These innovative projects are marshalling multidisciplinary teams of seasoned researchers from major Quebec research institutions.
Bangkok Hospital Group is working with IBM (NYSE: IBM) to enhance its patient care services to provide smarter healthcare in Thailand. Delivering on its commitment to provide the highest quality, internationally-accepted standards of medical services, Bangkok Hospital Group continues to invest in best-in-class information technology.
› Verified 2 days ago
| Provider Name | Walena Rochester |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1689455255 PECOS PAC ID: 7810333937 Enrollment ID: I20240312002216 |
News Archive
Over the past twenty years, the use of nanoparticles in medicine has steadily increased. However, their safety and effect on the human immune system remains an important concern.
GenVec, Inc. today announced that it has signed a research collaboration agreement with the Laboratory of Malaria Immunology and Vaccinology of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.
A small survey of U.S. obstetrics and gynecology residents finds that fewer than one in five receives formal training in menopause medicine, and that seven in 10 would like to receive it.
The first two research projects supported by the Pfizer-FRSQ Innovation Fund will investigate differences in the genetic code for inflammatory bowel disease and metastatic colorectal cancer. This research could lead to improved diagnosis and the development of individualized treatments for these diseases. These innovative projects are marshalling multidisciplinary teams of seasoned researchers from major Quebec research institutions.
Bangkok Hospital Group is working with IBM (NYSE: IBM) to enhance its patient care services to provide smarter healthcare in Thailand. Delivering on its commitment to provide the highest quality, internationally-accepted standards of medical services, Bangkok Hospital Group continues to invest in best-in-class information technology.
› Verified 2 days ago
News Archive
Over the past twenty years, the use of nanoparticles in medicine has steadily increased. However, their safety and effect on the human immune system remains an important concern.
GenVec, Inc. today announced that it has signed a research collaboration agreement with the Laboratory of Malaria Immunology and Vaccinology of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.
A small survey of U.S. obstetrics and gynecology residents finds that fewer than one in five receives formal training in menopause medicine, and that seven in 10 would like to receive it.
The first two research projects supported by the Pfizer-FRSQ Innovation Fund will investigate differences in the genetic code for inflammatory bowel disease and metastatic colorectal cancer. This research could lead to improved diagnosis and the development of individualized treatments for these diseases. These innovative projects are marshalling multidisciplinary teams of seasoned researchers from major Quebec research institutions.
Bangkok Hospital Group is working with IBM (NYSE: IBM) to enhance its patient care services to provide smarter healthcare in Thailand. Delivering on its commitment to provide the highest quality, internationally-accepted standards of medical services, Bangkok Hospital Group continues to invest in best-in-class information technology.
› Verified 2 days ago
Sante' Foundation Medical Group Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 7370 N Palm Ave Ste 101, Fresno, CA 93711 Phone: 559-228-5400 | |
Sequoia Community Health Centers Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 302 Fresno St Ste 102, Fresno, CA 93706 Phone: 559-457-5700 Fax: 559-457-5790 | |
Fresno Healthcare Center, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3233 N Chestnut Ave Ste 102, Fresno, CA 93726 Phone: 559-456-1167 Fax: 559-456-1183 | |
Valley Pediatric Medical Group Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 7130 N Sharon Ave Ste 101, Fresno, CA 93720 Phone: 559-436-8606 Fax: 559-436-8654 | |
Dizon Medicine Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 7035 N Maple Ave Ste 102b, Fresno, CA 93720 Phone: 559-299-2997 | |
United Health Centers Of The San Joaquin Valley Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2630 Tuolumne St, Fresno, CA 93721 Phone: 800-492-4227 Fax: 559-646-6614 |